ATE15598T1 - Wismut enthaltende zusammensetzung und ein verfahren zu deren herstellung. - Google Patents

Wismut enthaltende zusammensetzung und ein verfahren zu deren herstellung.

Info

Publication number
ATE15598T1
ATE15598T1 AT82201167T AT82201167T ATE15598T1 AT E15598 T1 ATE15598 T1 AT E15598T1 AT 82201167 T AT82201167 T AT 82201167T AT 82201167 T AT82201167 T AT 82201167T AT E15598 T1 ATE15598 T1 AT E15598T1
Authority
AT
Austria
Prior art keywords
bismuth
containing composition
preparation
composition
new
Prior art date
Application number
AT82201167T
Other languages
German (de)
English (en)
Inventor
Petrus Johannes Hugo Bos
Dirk Jacob Coenraad Engel
Jonge Hayo De
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Application granted granted Critical
Publication of ATE15598T1 publication Critical patent/ATE15598T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Supply, Installation And Extraction Of Printed Sheets Or Plates (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
  • Cereal-Derived Products (AREA)
AT82201167T 1981-09-22 1982-09-21 Wismut enthaltende zusammensetzung und ein verfahren zu deren herstellung. ATE15598T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30437281A 1981-09-22 1981-09-22
EP82201167A EP0075992B1 (en) 1981-09-22 1982-09-21 Bismuth containing composition and method for the preparation thereof

Publications (1)

Publication Number Publication Date
ATE15598T1 true ATE15598T1 (de) 1985-10-15

Family

ID=23176246

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82201167T ATE15598T1 (de) 1981-09-22 1982-09-21 Wismut enthaltende zusammensetzung und ein verfahren zu deren herstellung.

Country Status (17)

Country Link
EP (1) EP0075992B1 (enExample)
JP (1) JPS58501590A (enExample)
AT (1) ATE15598T1 (enExample)
AU (1) AU563692B2 (enExample)
CA (1) CA1198367A (enExample)
DE (1) DE3266403D1 (enExample)
DK (1) DK160533C (enExample)
ES (1) ES8400240A1 (enExample)
FI (1) FI77156C (enExample)
GR (1) GR78040B (enExample)
HU (1) HU193524B (enExample)
IE (1) IE53958B1 (enExample)
NZ (1) NZ201911A (enExample)
PH (1) PH20649A (enExample)
PT (1) PT75550B (enExample)
WO (1) WO1983001001A1 (enExample)
ZA (1) ZA826893B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG72632A1 (en) * 1985-04-18 2000-05-23 Procter & Gamble Treatment of non-ulcer dyspepsia with bismuth salts
EP0206625B1 (en) * 1985-06-13 1992-09-30 Barry James Dr. Marshall Compositions for the treatment of gastrointestinal disorders
EP0206627B1 (en) * 1985-06-13 1992-08-12 Barry James Dr. Marshall Methods for the treatment of gastrointestinal disorders
HU205861B (en) * 1986-12-19 1992-07-28 Sandoz Ag Process for producing hydrosole of pharmaceutically effective material
DE3901508C2 (de) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
IT1229502B (it) * 1989-01-25 1991-09-03 Euroresearch Srl Composizioni contenenti bismuto idonee per uso terapeutico.
IE893167A1 (en) * 1989-10-04 1991-04-24 Ulso Lab Ltd Preparation of orally administrable liquids for use in¹therapy
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
AU5019196A (en) * 1995-02-07 1996-08-27 Narayan Krishnarao Athanikar Concomitant treatment with oral bismuth compounds
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
ES2267108T3 (es) * 1995-08-24 2007-03-01 Josman Laboratories, Inc. Composiciones que contienen bismuto en formas de dosificacion topicas.
RU2189942C1 (ru) * 2001-06-26 2002-09-27 Институт химии твердого тела и механохимии СО РАН Способ получения висмут-калий-аммоний цитрата
RU2416571C1 (ru) * 2010-02-15 2011-04-20 Учреждение Российской академии наук Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмута цитрата
RU2496719C1 (ru) * 2012-02-17 2013-10-27 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмут калий цитрата
RU2570610C1 (ru) * 2014-10-02 2015-12-10 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмут аммоний цитрата
RU2675869C1 (ru) * 2018-02-05 2018-12-25 Общество с ограниченной ответственностью "Брайт Вэй" Способ получения висмут-калий-аммоний цитрата

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA74385B (en) * 1974-01-18 1975-08-27 Gist Brocades Nv Pharmaceutical compositions

Also Published As

Publication number Publication date
DE3266403D1 (en) 1985-10-24
FI831815A0 (fi) 1983-05-20
EP0075992A1 (en) 1983-04-06
DK208083A (da) 1983-05-10
JPS58501590A (ja) 1983-09-22
ZA826893B (en) 1983-07-27
HU193524B (en) 1987-10-28
IE822299L (en) 1983-03-22
IE53958B1 (en) 1989-04-26
NZ201911A (en) 1985-10-11
GR78040B (enExample) 1984-09-26
DK208083D0 (da) 1983-05-10
FI77156B (fi) 1988-10-31
EP0075992B1 (en) 1985-09-18
JPH0330573B2 (enExample) 1991-04-30
WO1983001001A1 (en) 1983-03-31
CA1198367A (en) 1985-12-24
DK160533C (da) 1991-09-09
PT75550B (en) 1984-12-12
FI77156C (fi) 1989-02-10
DK160533B (da) 1991-03-25
FI831815L (fi) 1983-05-20
AU8950382A (en) 1983-04-08
ES515848A0 (es) 1983-10-16
PT75550A (en) 1982-10-01
PH20649A (en) 1987-03-16
AU563692B2 (en) 1987-07-16
ES8400240A1 (es) 1983-10-16

Similar Documents

Publication Publication Date Title
ATE15598T1 (de) Wismut enthaltende zusammensetzung und ein verfahren zu deren herstellung.
ATE46161T1 (de) Verfahren zur herstellung von pyridin-2,3dicarbons|urederivaten und neue 1-amino-1,2,3,4tetrahydropyridin-2,3-dicarbons|urederivate und 1,4-dihydropyridin-2,3-dicarbonsaeurederivate.
GB2109257B (en) Apparatus of treatment of urea solutions
KR840004667A (ko) 3,7,11,15-테트라메틸-2,4,6,10,14-헥사데카펜타엔산의 제조방법
DE3578135D1 (de) Behandlung eines ultrafiltrats durch elektrodialyse.
DE3580723D1 (de) Verfahren fuer die behandlung von gelagertem material (schlaemmen) aus der chemischen behandlung der verbrauchten schwefelsaeure mit kalk.
ATA112277A (de) Verfahren zur herstellung von neuen 2,9-dioxa- tricyclo (4,3,1,03,7) decanen und deren salzen
AT346827B (de) Verfahren zur herstellung von neuen 3- aminomethyl-2-phenyl-bicyclo (2,2,2) octanen und -octenen sowie deren saeureadditionssalzen
ATA566479A (de) Verbessertes verfahren zur herstellung von hydroxymethyl-4(5)-niedrigem-alkyl-5(4)-imidazo en und deren sauren additionssalzen
DE2961147D1 (en) Process for the preparation of 4-nitro-4'-amino-diphenyl-amino-2-sulfonic acid and 2-nitro-4'-amino-diphenyl-amino-4-sulfonic acid
JPS558875A (en) Denitrification catalyst with porous coat
SU583115A1 (ru) Способ очистки водных растворов формальдегида
AT351030B (de) Verfahren zur herstellung von neuen 1,2- dihydro-6-phenyl-1h,4h-imidazo (1,2a) (1,4) benzodiazepin-1-onen sowie von deren saeure- additionssalzen
GB2031413B (en) 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for their preparation thereof
JPS54121296A (en) Method of removing arsenic from as contained concentrated ferrous sulfate aqueous solution
AT352136B (de) Verfahren zur herstellung von neuen 1,5,10,10a- tetrahydrothiazolo-(3,4-b) -isochinolin-derivaten und von deren saeure- additionssalzen
GB2031411B (en) 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof
JPS5333864A (en) Method of use of tannic acid compound
PT74363B (en) Process for preparing sparingly water-soluble salts of penicil-lanic acid 1,1-dioxide
JPS5424863A (en) 2-pheyl anthraquinonedisulfonic acid, and its salts, their preparation, oxidation-reduction agents for wet desulfurization using them
JPS5211194A (en) Method for controlling basicity of basic aluminum sulfate solution
JPS5398153A (en) Method of treating sludge exuded foul water
JPS5319172A (en) Treating method for oxidation
PT75108B (de) Neue 1-substituierte imidazo <1,2-a>imidazole deren saureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
BE877937A (fr) Compose chimique heterocyclique 6-phenyl 1,2,3, oxadiazolo-(4,5d) pyridazine-7(6h)-one et procede pour sa prepaeation